source
- China targets five $1 billion blockbuster drugs by 2030, two already achievedChina's latest five-year plan aims to develop five domestically created drugs that each generate over $1 billion in global sales by 2030. According to industry analysts, two drugs have already sur…
- Boehringer bets big on China, offering $7B biobucks for Sino cancer programsBoehringer Ingelheim is building up its China strategy, inking a deal to develop new cancer treatments with Sino Biopharmaceutical just weeks after opening an R&D facility in Shanghai.